カテゴリー： Market Monitor Global, 世界, 医療/バイオ

非侵襲的DNA出生前検査のグローバル市場展望 2023年-2029年：装備品、消耗品

◆英語タイトル：Non-invasive DNA Prenatal Testing Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23DC16259）

◆商品コード：MMG23DC16259
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年12月
◆ページ数：106
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医療機器＆消耗品

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界の非侵襲的DNA出生前検査市場規模と予測を収録しています。・世界の非侵襲的DNA出生前検査市場：売上、2018年-2023年、2024年-2029年
・世界の非侵襲的DNA出生前検査市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の非侵襲的DNA出生前検査市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「装備品」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

非侵襲的DNA出生前検査のグローバル主要企業は、Illumina、 Roche、 Natera、 Thermo Fisher Scientific、 F. Hoffman-La Roche、 Pacific Biosciences Of California、 Perkinelmer、 LifeCodexx、 Agilent Technologies、 Labcorp、 Mutiplicon、 Premaitha Health、 Beijing BGI、 Berry Genomics、 Darui Biologicalなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、非侵襲的DNA出生前検査のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の非侵襲的DNA出生前検査市場：タイプ別、2018年-2023年、2024年-2029年
世界の非侵襲的DNA出生前検査市場：タイプ別市場シェア、2022年
・装備品、消耗品

世界の非侵襲的DNA出生前検査市場：用途別、2018年-2023年、2024年-2029年
世界の非侵襲的DNA出生前検査市場：用途別市場シェア、2022年
・病院、診療所、その他

世界の非侵襲的DNA出生前検査市場：地域・国別、2018年-2023年、2024年-2029年
世界の非侵襲的DNA出生前検査市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における非侵襲的DNA出生前検査のグローバル売上、2018年-2023年
・主要企業における非侵襲的DNA出生前検査のグローバル売上シェア、2022年
・主要企業における非侵襲的DNA出生前検査のグローバル販売量、2018年-2023年
・主要企業における非侵襲的DNA出生前検査のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Illumina、 Roche、 Natera、 Thermo Fisher Scientific、 F. Hoffman-La Roche、 Pacific Biosciences Of California、 Perkinelmer、 LifeCodexx、 Agilent Technologies、 Labcorp、 Mutiplicon、 Premaitha Health、 Beijing BGI、 Berry Genomics、 Darui Biological

*************************************************************

・調査・分析レポートの概要
非侵襲的DNA出生前検査市場の定義
市場セグメント
世界の非侵襲的DNA出生前検査市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の非侵襲的DNA出生前検査市場規模
世界の非侵襲的DNA出生前検査市場規模：2022年 VS 2029年
世界の非侵襲的DNA出生前検査市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの非侵襲的DNA出生前検査の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の非侵襲的DNA出生前検査製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：装備品、消耗品
非侵襲的DNA出生前検査のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、診療所、その他
非侵襲的DNA出生前検査の用途別グローバル売上・予測

・地域別市場分析
地域別非侵襲的DNA出生前検査市場規模 2022年と2029年
地域別非侵襲的DNA出生前検査売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Illumina、 Roche、 Natera、 Thermo Fisher Scientific、 F. Hoffman-La Roche、 Pacific Biosciences Of California、 Perkinelmer、 LifeCodexx、 Agilent Technologies、 Labcorp、 Mutiplicon、 Premaitha Health、 Beijing BGI、 Berry Genomics、 Darui Biological
...

This research report provides a comprehensive analysis of the Non-invasive DNA Prenatal Testing market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Non-invasive DNA Prenatal Testing market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Non-invasive DNA Prenatal Testing, challenges faced by the industry, and potential opportunities for market players.
The global Non-invasive DNA Prenatal Testing market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Non-invasive DNA Prenatal Testing market presents opportunities for various stakeholders, including Hospital, Clinic. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Non-invasive DNA Prenatal Testing market. Additionally, the growing consumer demand present avenues for market expansion.
The global Non-invasive DNA Prenatal Testing market was valued at US$ 4435.8 million in 2022 and is projected to reach US$ 10140 million by 2029, at a CAGR of 12.6% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Key Features:
The research report on the Non-invasive DNA Prenatal Testing market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Non-invasive DNA Prenatal Testing market.
Market Overview: The report provides a comprehensive overview of the Non-invasive DNA Prenatal Testing market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Equipment, Consumables), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Non-invasive DNA Prenatal Testing market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Non-invasive DNA Prenatal Testing market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Non-invasive DNA Prenatal Testing market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Non-invasive DNA Prenatal Testing market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Non-invasive DNA Prenatal Testing market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Non-invasive DNA Prenatal Testing market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Non-invasive DNA Prenatal Testing, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Non-invasive DNA Prenatal Testing market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Non-invasive DNA Prenatal Testing market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Equipment
Consumables
Market segment by Application
Hospital
Clinic
Other
Global Non-invasive DNA Prenatal Testing Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Illumina
Roche
Natera
Thermo Fisher Scientific
F. Hoffman-La Roche
Pacific Biosciences Of California
Perkinelmer
LifeCodexx
Agilent Technologies
Labcorp
Mutiplicon
Premaitha Health
Beijing BGI
Berry Genomics
Darui Biological
Outline of Major Chapters:
Chapter 1: Introduces the definition of Non-invasive DNA Prenatal Testing, market overview.
Chapter 2: Global Non-invasive DNA Prenatal Testing market size in revenue.
Chapter 3: Detailed analysis of Non-invasive DNA Prenatal Testing company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Non-invasive DNA Prenatal Testing in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Non-invasive DNA Prenatal Testing Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Non-invasive DNA Prenatal Testing Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Non-invasive DNA Prenatal Testing Overall Market Size
2.1 Global Non-invasive DNA Prenatal Testing Market Size: 2022 VS 2029
2.2 Global Non-invasive DNA Prenatal Testing Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Non-invasive DNA Prenatal Testing Players in Global Market
3.2 Top Global Non-invasive DNA Prenatal Testing Companies Ranked by Revenue
3.3 Global Non-invasive DNA Prenatal Testing Revenue by Companies
3.4 Top 3 and Top 5 Non-invasive DNA Prenatal Testing Companies in Global Market, by Revenue in 2022
3.5 Global Companies Non-invasive DNA Prenatal Testing Product Type
3.6 Tier 1, Tier 2 and Tier 3 Non-invasive DNA Prenatal Testing Players in Global Market
3.6.1 List of Global Tier 1 Non-invasive DNA Prenatal Testing Companies
3.6.2 List of Global Tier 2 and Tier 3 Non-invasive DNA Prenatal Testing Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Non-invasive DNA Prenatal Testing Market Size Markets, 2022 & 2029
4.1.2 Equipment
4.1.3 Consumables
4.2 By Type – Global Non-invasive DNA Prenatal Testing Revenue & Forecasts
4.2.1 By Type – Global Non-invasive DNA Prenatal Testing Revenue, 2018-2023
4.2.2 By Type – Global Non-invasive DNA Prenatal Testing Revenue, 2024-2029
4.2.3 By Type – Global Non-invasive DNA Prenatal Testing Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Non-invasive DNA Prenatal Testing Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Other
5.2 By Application – Global Non-invasive DNA Prenatal Testing Revenue & Forecasts
5.2.1 By Application – Global Non-invasive DNA Prenatal Testing Revenue, 2018-2023
5.2.2 By Application – Global Non-invasive DNA Prenatal Testing Revenue, 2024-2029
5.2.3 By Application – Global Non-invasive DNA Prenatal Testing Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Non-invasive DNA Prenatal Testing Market Size, 2022 & 2029
6.2 By Region – Global Non-invasive DNA Prenatal Testing Revenue & Forecasts
6.2.1 By Region – Global Non-invasive DNA Prenatal Testing Revenue, 2018-2023
6.2.2 By Region – Global Non-invasive DNA Prenatal Testing Revenue, 2024-2029
6.2.3 By Region – Global Non-invasive DNA Prenatal Testing Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Non-invasive DNA Prenatal Testing Revenue, 2018-2029
6.3.2 US Non-invasive DNA Prenatal Testing Market Size, 2018-2029
6.3.3 Canada Non-invasive DNA Prenatal Testing Market Size, 2018-2029
6.3.4 Mexico Non-invasive DNA Prenatal Testing Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Non-invasive DNA Prenatal Testing Revenue, 2018-2029
6.4.2 Germany Non-invasive DNA Prenatal Testing Market Size, 2018-2029
6.4.3 France Non-invasive DNA Prenatal Testing Market Size, 2018-2029
6.4.4 U.K. Non-invasive DNA Prenatal Testing Market Size, 2018-2029
6.4.5 Italy Non-invasive DNA Prenatal Testing Market Size, 2018-2029
6.4.6 Russia Non-invasive DNA Prenatal Testing Market Size, 2018-2029
6.4.7 Nordic Countries Non-invasive DNA Prenatal Testing Market Size, 2018-2029
6.4.8 Benelux Non-invasive DNA Prenatal Testing Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Non-invasive DNA Prenatal Testing Revenue, 2018-2029
6.5.2 China Non-invasive DNA Prenatal Testing Market Size, 2018-2029
6.5.3 Japan Non-invasive DNA Prenatal Testing Market Size, 2018-2029
6.5.4 South Korea Non-invasive DNA Prenatal Testing Market Size, 2018-2029
6.5.5 Southeast Asia Non-invasive DNA Prenatal Testing Market Size, 2018-2029
6.5.6 India Non-invasive DNA Prenatal Testing Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Non-invasive DNA Prenatal Testing Revenue, 2018-2029
6.6.2 Brazil Non-invasive DNA Prenatal Testing Market Size, 2018-2029
6.6.3 Argentina Non-invasive DNA Prenatal Testing Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Non-invasive DNA Prenatal Testing Revenue, 2018-2029
6.7.2 Turkey Non-invasive DNA Prenatal Testing Market Size, 2018-2029
6.7.3 Israel Non-invasive DNA Prenatal Testing Market Size, 2018-2029
6.7.4 Saudi Arabia Non-invasive DNA Prenatal Testing Market Size, 2018-2029
6.7.5 UAE Non-invasive DNA Prenatal Testing Market Size, 2018-2029
7 Non-invasive DNA Prenatal Testing Companies Profiles
7.1 Illumina
7.1.1 Illumina Company Summary
7.1.2 Illumina Business Overview
7.1.3 Illumina Non-invasive DNA Prenatal Testing Major Product Offerings
7.1.4 Illumina Non-invasive DNA Prenatal Testing Revenue in Global Market (2018-2023)
7.1.5 Illumina Key News & Latest Developments
7.2 Roche
7.2.1 Roche Company Summary
7.2.2 Roche Business Overview
7.2.3 Roche Non-invasive DNA Prenatal Testing Major Product Offerings
7.2.4 Roche Non-invasive DNA Prenatal Testing Revenue in Global Market (2018-2023)
7.2.5 Roche Key News & Latest Developments
7.3 Natera
7.3.1 Natera Company Summary
7.3.2 Natera Business Overview
7.3.3 Natera Non-invasive DNA Prenatal Testing Major Product Offerings
7.3.4 Natera Non-invasive DNA Prenatal Testing Revenue in Global Market (2018-2023)
7.3.5 Natera Key News & Latest Developments
7.4 Thermo Fisher Scientific
7.4.1 Thermo Fisher Scientific Company Summary
7.4.2 Thermo Fisher Scientific Business Overview
7.4.3 Thermo Fisher Scientific Non-invasive DNA Prenatal Testing Major Product Offerings
7.4.4 Thermo Fisher Scientific Non-invasive DNA Prenatal Testing Revenue in Global Market (2018-2023)
7.4.5 Thermo Fisher Scientific Key News & Latest Developments
7.5 F. Hoffman-La Roche
7.5.1 F. Hoffman-La Roche Company Summary
7.5.2 F. Hoffman-La Roche Business Overview
7.5.3 F. Hoffman-La Roche Non-invasive DNA Prenatal Testing Major Product Offerings
7.5.4 F. Hoffman-La Roche Non-invasive DNA Prenatal Testing Revenue in Global Market (2018-2023)
7.5.5 F. Hoffman-La Roche Key News & Latest Developments
7.6 Pacific Biosciences Of California
7.6.1 Pacific Biosciences Of California Company Summary
7.6.2 Pacific Biosciences Of California Business Overview
7.6.3 Pacific Biosciences Of California Non-invasive DNA Prenatal Testing Major Product Offerings
7.6.4 Pacific Biosciences Of California Non-invasive DNA Prenatal Testing Revenue in Global Market (2018-2023)
7.6.5 Pacific Biosciences Of California Key News & Latest Developments
7.7 Perkinelmer
7.7.1 Perkinelmer Company Summary
7.7.2 Perkinelmer Business Overview
7.7.3 Perkinelmer Non-invasive DNA Prenatal Testing Major Product Offerings
7.7.4 Perkinelmer Non-invasive DNA Prenatal Testing Revenue in Global Market (2018-2023)
7.7.5 Perkinelmer Key News & Latest Developments
7.8 LifeCodexx
7.8.1 LifeCodexx Company Summary
7.8.2 LifeCodexx Business Overview
7.8.3 LifeCodexx Non-invasive DNA Prenatal Testing Major Product Offerings
7.8.4 LifeCodexx Non-invasive DNA Prenatal Testing Revenue in Global Market (2018-2023)
7.8.5 LifeCodexx Key News & Latest Developments
7.9 Agilent Technologies
7.9.1 Agilent Technologies Company Summary
7.9.2 Agilent Technologies Business Overview
7.9.3 Agilent Technologies Non-invasive DNA Prenatal Testing Major Product Offerings
7.9.4 Agilent Technologies Non-invasive DNA Prenatal Testing Revenue in Global Market (2018-2023)
7.9.5 Agilent Technologies Key News & Latest Developments
7.10 Labcorp
7.10.1 Labcorp Company Summary
7.10.2 Labcorp Business Overview
7.10.3 Labcorp Non-invasive DNA Prenatal Testing Major Product Offerings
7.10.4 Labcorp Non-invasive DNA Prenatal Testing Revenue in Global Market (2018-2023)
7.10.5 Labcorp Key News & Latest Developments
7.11 Mutiplicon
7.11.1 Mutiplicon Company Summary
7.11.2 Mutiplicon Business Overview
7.11.3 Mutiplicon Non-invasive DNA Prenatal Testing Major Product Offerings
7.11.4 Mutiplicon Non-invasive DNA Prenatal Testing Revenue in Global Market (2018-2023)
7.11.5 Mutiplicon Key News & Latest Developments
7.12 Premaitha Health
7.12.1 Premaitha Health Company Summary
7.12.2 Premaitha Health Business Overview
7.12.3 Premaitha Health Non-invasive DNA Prenatal Testing Major Product Offerings
7.12.4 Premaitha Health Non-invasive DNA Prenatal Testing Revenue in Global Market (2018-2023)
7.12.5 Premaitha Health Key News & Latest Developments
7.13 Beijing BGI
7.13.1 Beijing BGI Company Summary
7.13.2 Beijing BGI Business Overview
7.13.3 Beijing BGI Non-invasive DNA Prenatal Testing Major Product Offerings
7.13.4 Beijing BGI Non-invasive DNA Prenatal Testing Revenue in Global Market (2018-2023)
7.13.5 Beijing BGI Key News & Latest Developments
7.14 Berry Genomics
7.14.1 Berry Genomics Company Summary
7.14.2 Berry Genomics Business Overview
7.14.3 Berry Genomics Non-invasive DNA Prenatal Testing Major Product Offerings
7.14.4 Berry Genomics Non-invasive DNA Prenatal Testing Revenue in Global Market (2018-2023)
7.14.5 Berry Genomics Key News & Latest Developments
7.15 Darui Biological
7.15.1 Darui Biological Company Summary
7.15.2 Darui Biological Business Overview
7.15.3 Darui Biological Non-invasive DNA Prenatal Testing Major Product Offerings
7.15.4 Darui Biological Non-invasive DNA Prenatal Testing Revenue in Global Market (2018-2023)
7.15.5 Darui Biological Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Non-invasive DNA Prenatal Testing Market Opportunities & Trends in Global Market
Table 2. Non-invasive DNA Prenatal Testing Market Drivers in Global Market
Table 3. Non-invasive DNA Prenatal Testing Market Restraints in Global Market
Table 4. Key Players of Non-invasive DNA Prenatal Testing in Global Market
Table 5. Top Non-invasive DNA Prenatal Testing Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Non-invasive DNA Prenatal Testing Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Non-invasive DNA Prenatal Testing Revenue Share by Companies, 2018-2023
Table 8. Global Companies Non-invasive DNA Prenatal Testing Product Type
Table 9. List of Global Tier 1 Non-invasive DNA Prenatal Testing Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Non-invasive DNA Prenatal Testing Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Non-invasive DNA Prenatal Testing Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Non-invasive DNA Prenatal Testing Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Non-invasive DNA Prenatal Testing Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global Non-invasive DNA Prenatal Testing Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Non-invasive DNA Prenatal Testing Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Non-invasive DNA Prenatal Testing Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global Non-invasive DNA Prenatal Testing Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Non-invasive DNA Prenatal Testing Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Non-invasive DNA Prenatal Testing Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Non-invasive DNA Prenatal Testing Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Non-invasive DNA Prenatal Testing Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Non-invasive DNA Prenatal Testing Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Non-invasive DNA Prenatal Testing Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Non-invasive DNA Prenatal Testing Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Non-invasive DNA Prenatal Testing Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Non-invasive DNA Prenatal Testing Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Non-invasive DNA Prenatal Testing Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Non-invasive DNA Prenatal Testing Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Non-invasive DNA Prenatal Testing Revenue, (US$, Mn), 2024-2029
Table 30. Illumina Company Summary
Table 31. Illumina Non-invasive DNA Prenatal Testing Product Offerings
Table 32. Illumina Non-invasive DNA Prenatal Testing Revenue (US$, Mn) & (2018-2023)
Table 33. Illumina Key News & Latest Developments
Table 34. Roche Company Summary
Table 35. Roche Non-invasive DNA Prenatal Testing Product Offerings
Table 36. Roche Non-invasive DNA Prenatal Testing Revenue (US$, Mn) & (2018-2023)
Table 37. Roche Key News & Latest Developments
Table 38. Natera Company Summary
Table 39. Natera Non-invasive DNA Prenatal Testing Product Offerings
Table 40. Natera Non-invasive DNA Prenatal Testing Revenue (US$, Mn) & (2018-2023)
Table 41. Natera Key News & Latest Developments
Table 42. Thermo Fisher Scientific Company Summary
Table 43. Thermo Fisher Scientific Non-invasive DNA Prenatal Testing Product Offerings
Table 44. Thermo Fisher Scientific Non-invasive DNA Prenatal Testing Revenue (US$, Mn) & (2018-2023)
Table 45. Thermo Fisher Scientific Key News & Latest Developments
Table 46. F. Hoffman-La Roche Company Summary
Table 47. F. Hoffman-La Roche Non-invasive DNA Prenatal Testing Product Offerings
Table 48. F. Hoffman-La Roche Non-invasive DNA Prenatal Testing Revenue (US$, Mn) & (2018-2023)
Table 49. F. Hoffman-La Roche Key News & Latest Developments
Table 50. Pacific Biosciences Of California Company Summary
Table 51. Pacific Biosciences Of California Non-invasive DNA Prenatal Testing Product Offerings
Table 52. Pacific Biosciences Of California Non-invasive DNA Prenatal Testing Revenue (US$, Mn) & (2018-2023)
Table 53. Pacific Biosciences Of California Key News & Latest Developments
Table 54. Perkinelmer Company Summary
Table 55. Perkinelmer Non-invasive DNA Prenatal Testing Product Offerings
Table 56. Perkinelmer Non-invasive DNA Prenatal Testing Revenue (US$, Mn) & (2018-2023)
Table 57. Perkinelmer Key News & Latest Developments
Table 58. LifeCodexx Company Summary
Table 59. LifeCodexx Non-invasive DNA Prenatal Testing Product Offerings
Table 60. LifeCodexx Non-invasive DNA Prenatal Testing Revenue (US$, Mn) & (2018-2023)
Table 61. LifeCodexx Key News & Latest Developments
Table 62. Agilent Technologies Company Summary
Table 63. Agilent Technologies Non-invasive DNA Prenatal Testing Product Offerings
Table 64. Agilent Technologies Non-invasive DNA Prenatal Testing Revenue (US$, Mn) & (2018-2023)
Table 65. Agilent Technologies Key News & Latest Developments
Table 66. Labcorp Company Summary
Table 67. Labcorp Non-invasive DNA Prenatal Testing Product Offerings
Table 68. Labcorp Non-invasive DNA Prenatal Testing Revenue (US$, Mn) & (2018-2023)
Table 69. Labcorp Key News & Latest Developments
Table 70. Mutiplicon Company Summary
Table 71. Mutiplicon Non-invasive DNA Prenatal Testing Product Offerings
Table 72. Mutiplicon Non-invasive DNA Prenatal Testing Revenue (US$, Mn) & (2018-2023)
Table 73. Mutiplicon Key News & Latest Developments
Table 74. Premaitha Health Company Summary
Table 75. Premaitha Health Non-invasive DNA Prenatal Testing Product Offerings
Table 76. Premaitha Health Non-invasive DNA Prenatal Testing Revenue (US$, Mn) & (2018-2023)
Table 77. Premaitha Health Key News & Latest Developments
Table 78. Beijing BGI Company Summary
Table 79. Beijing BGI Non-invasive DNA Prenatal Testing Product Offerings
Table 80. Beijing BGI Non-invasive DNA Prenatal Testing Revenue (US$, Mn) & (2018-2023)
Table 81. Beijing BGI Key News & Latest Developments
Table 82. Berry Genomics Company Summary
Table 83. Berry Genomics Non-invasive DNA Prenatal Testing Product Offerings
Table 84. Berry Genomics Non-invasive DNA Prenatal Testing Revenue (US$, Mn) & (2018-2023)
Table 85. Berry Genomics Key News & Latest Developments
Table 86. Darui Biological Company Summary
Table 87. Darui Biological Non-invasive DNA Prenatal Testing Product Offerings
Table 88. Darui Biological Non-invasive DNA Prenatal Testing Revenue (US$, Mn) & (2018-2023)
Table 89. Darui Biological Key News & Latest Developments
List of Figures
Figure 1. Non-invasive DNA Prenatal Testing Segment by Type in 2022
Figure 2. Non-invasive DNA Prenatal Testing Segment by Application in 2022
Figure 3. Global Non-invasive DNA Prenatal Testing Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Non-invasive DNA Prenatal Testing Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Non-invasive DNA Prenatal Testing Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Non-invasive DNA Prenatal Testing Revenue in 2022
Figure 8. By Type - Global Non-invasive DNA Prenatal Testing Revenue Market Share, 2018-2029
Figure 9. By Application - Global Non-invasive DNA Prenatal Testing Revenue Market Share, 2018-2029
Figure 10. By Type - Global Non-invasive DNA Prenatal Testing Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Non-invasive DNA Prenatal Testing Revenue Market Share, 2018-2029
Figure 12. By Application - Global Non-invasive DNA Prenatal Testing Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Non-invasive DNA Prenatal Testing Revenue Market Share, 2018-2029
Figure 14. By Region - Global Non-invasive DNA Prenatal Testing Revenue Market Share, 2018-2029
Figure 15. By Country - North America Non-invasive DNA Prenatal Testing Revenue Market Share, 2018-2029
Figure 16. US Non-invasive DNA Prenatal Testing Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Non-invasive DNA Prenatal Testing Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Non-invasive DNA Prenatal Testing Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Non-invasive DNA Prenatal Testing Revenue Market Share, 2018-2029
Figure 20. Germany Non-invasive DNA Prenatal Testing Revenue, (US$, Mn), 2018-2029
Figure 21. France Non-invasive DNA Prenatal Testing Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Non-invasive DNA Prenatal Testing Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Non-invasive DNA Prenatal Testing Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Non-invasive DNA Prenatal Testing Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Non-invasive DNA Prenatal Testing Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Non-invasive DNA Prenatal Testing Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Non-invasive DNA Prenatal Testing Revenue Market Share, 2018-2029
Figure 28. China Non-invasive DNA Prenatal Testing Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Non-invasive DNA Prenatal Testing Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Non-invasive DNA Prenatal Testing Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Non-invasive DNA Prenatal Testing Revenue, (US$, Mn), 2018-2029
Figure 32. India Non-invasive DNA Prenatal Testing Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Non-invasive DNA Prenatal Testing Revenue Market Share, 2018-2029
Figure 34. Brazil Non-invasive DNA Prenatal Testing Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Non-invasive DNA Prenatal Testing Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Non-invasive DNA Prenatal Testing Revenue Market Share, 2018-2029
Figure 37. Turkey Non-invasive DNA Prenatal Testing Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Non-invasive DNA Prenatal Testing Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Non-invasive DNA Prenatal Testing Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Non-invasive DNA Prenatal Testing Revenue, (US$, Mn), 2018-2029
Figure 41. Illumina Non-invasive DNA Prenatal Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Roche Non-invasive DNA Prenatal Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Natera Non-invasive DNA Prenatal Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Thermo Fisher Scientific Non-invasive DNA Prenatal Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. F. Hoffman-La Roche Non-invasive DNA Prenatal Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Pacific Biosciences Of California Non-invasive DNA Prenatal Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Perkinelmer Non-invasive DNA Prenatal Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. LifeCodexx Non-invasive DNA Prenatal Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Agilent Technologies Non-invasive DNA Prenatal Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Labcorp Non-invasive DNA Prenatal Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Mutiplicon Non-invasive DNA Prenatal Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Premaitha Health Non-invasive DNA Prenatal Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Beijing BGI Non-invasive DNA Prenatal Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Berry Genomics Non-invasive DNA Prenatal Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Darui Biological Non-invasive DNA Prenatal Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 非侵襲的DNA出生前検査のグローバル市場展望 2023年-2029年：装備品、消耗品(Non-invasive DNA Prenatal Testing Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

非侵襲的DNA出生前検査のグローバル市場展望 2023年-2029年：装備品、消耗品

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp